
Quinazoline and Quinoline Derivatives
Quinazolines and quinolines are nitrogen-containing heterocyclic compounds with aromatic structures that play a key role in the synthesis of drugs with anticancer, antimicrobial, and anti-inflammatory activity. Their derivatives feature structural modifications that optimise bioavailability and selectivity, enabling the development of new active ingredients for various therapeutic applications. These compounds are used in the manufacture of APIs for the treatment of cancer, infections, neurodegenerative diseases, and cardiovascular conditions. Additionally, quinazoline and quinoline derivatives are essential in the research of enzyme inhibitors and the design of innovative bioactive molecules.
At CymitQuimica, we offer high-purity quinazoline and quinoline derivatives for applications in chemical synthesis, pharmaceutical development, and biotechnology.
Found 65576 products of "Quinazoline and Quinoline Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
1,3-Dimethyl-6-(1,3,5-trimethyl-1 H -pyrazol-4-yl)-1 H -pyrazolo[3,4- b ]pyridine-4-carboxylic acid
CAS:Purity:95+%Color and Shape:SolidMolecular weight:299.33401489257812-Amino-4-naphthalen-1-yl-thiophene-3-carboxylic acid methyl ester
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:283.3500061035156PK-11195
CAS:<p>M02235 - PK-11195</p>Formula:C21H21ClN2OPurity:>98%Color and Shape:SolidMolecular weight:352.86Aripiprazole metabolite-D6 (OPC-3373-D6), 0.1mg/ml in Ethanol
Formula:C13D6H9NO4Color and Shape:Single Solutiond,l-Methylphenidate.HCl, 1mg/ml in Methanol (as free base)
CAS:Controlled ProductColor and Shape:Single Solution2-Phenylquinoline-4-carboxylic acid hydrazide
CAS:Color and Shape:SolidMolecular weight:263.299987792968757-Hydroxy-4(2-pyridinyl)coumarin
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:239.229995727539062-Amino-4-biphenyl-4-yl-thiophene-3-carboxylic acid methyl ester
CAS:Purity:97%Color and Shape:SolidMolecular weight:309.38000488281251-Pyridin-3-yl-2,3,4,9-tetrahydro-1H-β-carboline-3-carboxylic acid
CAS:Purity:97%Color and Shape:SolidMolecular weight:293.325988769531254-Cyclopropyl-5-(2-methyl-2H-pyrazol-3-yl)-4H-[1,2,4]triazole-3-thiol
CAS:Purity:97%Color and Shape:SolidMolecular weight:221.0735163522-Amino-4-naphthalen-2-yl-thiophene-3-carboxylic acid methyl ester
CAS:Purity:95+%Color and Shape:SolidMolecular weight:283.3500061035156Perfluorophenyl 2-morpholino-5-(trifluoromethyl)benzoate
CAS:Purity:98%Molecular weight:441.27700805664066-Bromo-2-(3,4,5-trimethoxy-phenyl)-quinoline-4-carboxylic acid
CAS:Color and Shape:SolidMolecular weight:418.24301147460942-(4-Chlorophenyl)-quinoline-4-carboxylic acidhydrazide
CAS:Color and Shape:SolidMolecular weight:297.7399902343755-[(Morpholine-4-carbonyl)amino]naphthalene-1-sulfonyl chloride
CAS:Color and Shape:SolidMolecular weight:354.80999755859375Sibutramine Hydrochloride Monohydrate 1.0 mg/ml in Methanol (as anhydrous free base)
CAS:Color and Shape:Single SolutionPerfluorophenyl 2-(pyridin-3-yl)thiazole-4-carboxylate
CAS:Purity:98%Molecular weight:372.2699890136719Celecoxib Open Ring (4-((1,1,1-trifluoro-4-hydroxy-4-(p-tolyl)but-3-en-2-ylidene)amino)benzenesulfonamide)
Sulfonamides, nesoiFormula:C17H15F3N2O3SColor and Shape:Yellow SolidMolecular weight:384.07555Aripiprazole Spiro Analog (8-(2,3-dichlorophenyl)-5,8-diazaspiro[4.5]decan-5-ium, bromide)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C14H19Cl2N2·BrColor and Shape:White Off-White SolidMolecular weight:285.09253Omeprazole Magnesium
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C34H36MgN6O6S2Color and Shape:White Off-White PowderMolecular weight:712.19882Argatroban Related Compound B (Ethyl (4R)-1-[N^8-nitro-L-arginyl]-4-methylpiperidine-2-carboxylate dihydrochloride)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C15H28N6O5·2HClColor and Shape:Off-White PowderMolecular weight:444.16547Nadolol Related Compound F (1-(tert-Butylamino)-3-(naphthalen-1-yloxy)propan-2-ol)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormula:C17H23NO2Color and Shape:Off-White SolidMolecular weight:273.17288Methoxyethyl Phenol
CAS:Ether-phenols, ether-alcohol-phenols and their halogenated, sulfonated, nitrated or nitrosated derivativesFormula:C9H12O2Color and Shape:White PowderMolecular weight:152.08373Dofetilide Related Compound A (N-[4-(2-{2-[4-(Methanesulfonamido)phenoxy]ethylamino}ethyl)phenyl]methanesulfonamide)
CAS:Sulfonamides, nesoiFormula:C18H25N3O5S2Color and Shape:White PowderMolecular weight:427.12356Rivaroxaban Phthalimide ((S)-2-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)isoindoline-1,3-dione)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C21H21N3O5Color and Shape:White Off-White SolidMolecular weight:395.14812Rotigotine Related Compound K (7,8-Dihydronaphthalen-1-ol)
CAS:Monophenols not elsewhere specified or includedFormula:C10H10OColor and Shape:White Grey Brown Crystalline SolidMolecular weight:146.07316Clozapine
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormula:C18H19ClN4Color and Shape:Yellow PowderMolecular weight:326.12982Norepinephrine Related Compound E (2-Chloro-1-(3,4-dihydroxyphenyl)ethan-1-one)
CAS:Ketones and quinones, w/not with other oxygen function,and their halogenated,sulfated,nitrated,or nitrosated derivatives, nesoiFormula:C8H7ClO3Color and Shape:Dark Grey PowderMolecular weight:186.00837Apixaban Related Compound G (Ethyl 6-[4-(5-bromopentanamido)phenyl]-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS:Lactams, nesoiFormula:C27H29BrN4O5Color and Shape:Cream PowderMolecular weight:568.13213Refined Bleached Shellac
CAS:Natural gums, gum resins, resins and balsams nesoiColor and Shape:PowderSalmeterol Related Compound H (1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid, monohydrate)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormula:C36H43NO6·H2OColor and Shape:White SolidMolecular weight:603.3196Plerixafor
CAS:Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C28H54N8Color and Shape:White Off-White PowderMolecular weight:502.44714Sirolimus
CAS:Antibiotics nesoiFormula:C51H79NO13Color and Shape:Off-White White PowderMolecular weight:913.55514Fluphenazine Decanoate Dihydrochloride
CAS:Antidepressants, tranquilizers and other pschotherapeutic agentsFormula:C32H44F3N3O2S·2HClColor and Shape:White PowderMolecular weight:663.26399Argatroban Related Compound A ((2R,4R)-1-[N8-nitro- N2-(3-methylquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid)
CAS:Sulfonamides, nesoiFormula:C23H31N7O7SColor and Shape:White PowderMolecular weight:549.20057Celecoxib Related Compound A (4-[5-(3-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide)
CAS:Sulfonamides, nesoiFormula:C17H14F3N3O2SColor and Shape:White PowderMolecular weight:381.07588Rivaroxaban Ethyl Carbamate (ethyl (4-(3-oxomorpholino)phenyl)carbamate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C13H16N2O4Color and Shape:White Off-White SolidMolecular weight:264.11101Bupropion Amine Tosylate (2-Amino-1-(3-chloro-phenyl)-1-propanone 4-methylbenzenesulfonate)
CAS:Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormula:C16H18ClNO4SColor and Shape:White SolidMolecular weight:355.06451Levetiracetam Racemic Mixture (1:1 mixture of levetiracetam S-enantiomer-(2S)-2-(2-oxopyrrolidin-1-yl)butanamide and levetiracetam R-enantiomer (2R)-2-(2-oxopyrrolidin-1-yl)butanamide)
CAS:Lactams, nesoiFormula:C8H14N2O2Color and Shape:White Off-White PowderMolecular weight:170.10553N-Nitroso Bupropion (N-(tert-butyl)-N-(1-(3-chlorophenyl)-1-oxopropan-2-yl) nitrous amide)
CAS:Compounds with other nitrogen function, nesoiFormula:C13H17ClN2O2Color and Shape:SolidMolecular weight:268.09786Aripiprazole Related Compound G (7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}quinolin-2(1H)-one)
CAS:Lactams, nesoiFormula:C23H25Cl2N3O2Color and Shape:White Light Yellow Crystalline PowderMolecular weight:445.13238Bendroflumethiazide
CAS:Sulfonamides used as drugsFormula:C15H14F3N3O4S2Color and Shape:PowderMolecular weight:421.42Atazanavir Sulfate
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C38H52N6O7·H2SO4Color and Shape:White Pale Yellow PowderMolecular weight:802.35713Omeprazole Related Compound E (4-Methoxy-2-[[(RS)-(5-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-3,5-dimethylpyridine 1-oxide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C17H19N3O4SColor and Shape:Off-White PowderMolecular weight:361.10963Sildenafil Related Compound A (1-{[3-(6,7-Dihydro-1-methyl-7-oxo-3-isobutyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl}-4-methylpiperazine)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormula:C23H32N6O4SColor and Shape:White PowderMolecular weight:488.22057Duloxetine Related Compound A ((R)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C18H19NOS·HClColor and Shape:Off-White SolidMolecular weight:297.11874Dichlorothienoic Acid (4,5-dichlorothiophene-2-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C5H2Cl2O2SColor and Shape:Off-White SolidMolecular weight:195.91526Dehydroargatroban Trifluoroacetate ((2R,4R)-4-Methyl-1-{[(3-methylquinolin-8-yl)sulfonyl]-L-arginyl}piperidine-2-carboxylic acid Trifluoroacetate)
Sulfonamides, nesoiFormula:C23H32N6O5S·C2HF3O2Color and Shape:Off-White PowderMolecular weight:504.21549Salmeterol Related Compound A (4-[1-Hydroxy-2-(4-phenylbutylamino)ethyl]-2-(hydroxymethyl)phenol 1-hydroxy-2-naphthoate)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormula:C19H25NO3·C11H8O3Color and Shape:White PowderMolecular weight:315.18344Oxcarbazepine
CAS:Anticonvulsants, hypnotics and sedativesFormula:C15H12N2O2Color and Shape:Off-White Cream Light Orange PowderMolecular weight:252.08988Rotigotine O-Tosylate Hydrochloride ((S)-6-(propyl(2-(thiophen-2-yl)ethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-yl 4-methylbenzenesulfonate hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C26H32ClNO3S2Color and Shape:Off-White SolidMolecular weight:505.15121Brivaracetam Related Compound C ((R)-2-[(R)-2-Oxo-4-propylpyrrolidin-1-yl]butanamide)
CAS:Lactams, nesoiFormula:C11H20N2O2Color and Shape:White SolidMolecular weight:212.15248Gefitinib Related Compound A (7-Methoxy-6-(3-morpholinopropoxy)quinazolin-4(3H)-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H21N3O4Color and Shape:White Yellow PowderMolecular weight:319.15321Dealkyl Atazanavir (Methyl [(5S,10S,11S,14S)-11-benzyl-5-(tert-butyl)-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamate)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C26H43N5O7Color and Shape:White PowderMolecular weight:537.31625Argatroban
CAS:Sulfonamides used as drugsFormula:C23H36N6O5S·H2OColor and Shape:White Off-White PowderMolecular weight:526.25735Naproxen Related Compound G ((R)-2-(6-Methoxynaphthalen-2-yl)propanoic acid)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFormula:C14H14O3Color and Shape:PowderMolecular weight:230.09429Rivaroxaban Glycolic Acid Analog ((S)-2-(2-((4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)amino)ethoxy)acetic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H20ClN3O6SColor and Shape:Pale Yellow SolidMolecular weight:453.07613Atazanavir R,S,S,S-diastereomer (methyl [(5R,10S,11S,14S)-11-benzyl-5-tert-butyl-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-[[4-(pyridin-2-yl)phenyl]methyl]-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C38H52N6O7Color and Shape:Off-White SolidMolecular weight:704.38975Atazanavir amine analog methyl ((S)-1-(((2S,3S)-4-(2-((S)-2-amino-3,3-dimethylbutanoyl)-1-(4-(pyridin-2-yl)benzyl)hydrazinyl)-3-hydroxy-1-phenylbutan-2-yl)amino)-3,3-dimethyl-1-oxobutan-2-yl)carbamate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C36H50N6O5Color and Shape:Off-White SolidMolecular weight:646.38427Apixaban Related Compound H (Ethyl 6-[4-(5-chloropentanamido)phenyl]-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS:Lactams, nesoiFormula:C27H29ClN4O5Color and Shape:Off-White PowderMolecular weight:524.182655-Methylisoxazole-4-carboxylic Acid (5-Methyl-1,2-oxazole-4-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C5H5NO3Color and Shape:White SolidMolecular weight:127.02694Ambrisentan Related Compound C (2-[(4,6-Dimethylpyrimidin-2-yl)oxy]-3-hydroxy-3,3-diphenylpropanoic acid)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C21H20N2O4Color and Shape:White Off-White SolidMolecular weight:364.14231Omeprazole Related Compound C (5-Methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylthio]-1H-benzimidazole)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C17H19N3O2SColor and Shape:White Off-White PowderMolecular weight:329.1198Salmeterol Xinafoate
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-pheFormula:C25H37NO4·C11H8O3Color and Shape:White PowderMolecular weight:415.27226Sorafenib Isopropyl Carbamate (Isopropyl {4-[2-(methylcarbamoyl)pyridin-4-yl]oxyphenyl}carbamate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C17H19N3O4Color and Shape:Off-White PowderMolecular weight:329.13756Fluvoxamine Maleate
CAS:Aromatic organic derivatives of hydrazine or of hydroxylamineFormula:C15H21F3N2O2·C4H4O4Color and Shape:White Off-White Crystalline PowderMolecular weight:318.15551Brivaracetam Related Compound D ((S)-2-[(R)-2-Oxo-4-propylpyrrolidin-1-yl]butanoic acid)
CAS:Lactams, nesoiFormula:C11H19NO3Color and Shape:White Off-White Fine PowderMolecular weight:213.13649Metoprolol Related Compound C (4-[2-Hydroxy-3-(isopropylamino)propoxy]benzaldehyde hydrochloride)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormula:C13H19NO3·HClColor and Shape:White PowderMolecular weight:237.13649Carvedilol Related Compound E (2-(2-Methoxyphenoxy)ethyl amine hydrochloride monohydrate)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormula:C9H13NO2Color and Shape:Off-White PowderMolecular weight:167.09463Crospovidone
CAS:Other vinyl polymers in primary forms,nesoiFormula:(C6H9NO)nColor and Shape:White Off-White PowderMolecular weight:177.121Rivaroxaban Desthiophene Analog ((R)-4-(4-(5-(aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C14H17N3O4Color and Shape:White Off-White SolidMolecular weight:291.12191Metoprolol Tartrate
CAS:Aromatic drugs of amino-alcohols, other than those contg more than one kind of oxygen function, their ethers and esters; salts thereof, nesoiFormula:C15H25NO3C4H6O6Color and Shape:White Crystalline PowderMolecular weight:684.81Methylparaben
CAS:Carboxylic acids with phenol function but without otherFormula:C8H8O3Color and Shape:White Crystalline PowderMolecular weight:152.15Saxagliptin Related Compound B (Saxagliptin amide analog (1S,3S,5S)-2-{(S)-2-Amino-2-[(1r,3R,5R,7S)-3-hydroxyadamantan-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carboxamide)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormula:C18H27N3O3Color and Shape:White Fine PowderMolecular weight:333.20524Desthiophenerivaroxaban Phthalimodo Analog ((R)-2-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)isoindoline-1,3-dione)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C22H19N3O6Color and Shape:White Off-White SolidMolecular weight:421.12739Duloxetine Hydrochloride
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C18H19NOS·HClColor and Shape:White Off-White PowderMolecular weight:297.11874Sorbitol
CAS:D-glucitol (sorbitol)Formula:C6H14O6Color and Shape:White Crystalline PowderMolecular weight:182.17 g/molCarvedilol Bisalkylpyrocatechol derivative (3,3'-{2,2'-[1,2-Phenylenebis(oxy)]bis(ethane-2,1-diyl)}bis(azanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol))
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C40H42N4O6Color and Shape:Off-White Light Brown SolidMolecular weight:674.31044Rotigotine ((S)-6-{Propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H25NOSColor and Shape:White Beige PowderMolecular weight:315.16569Dofetilide Related Compound B (N-Methyl-N-[4-(methylsulfonamido)phenethyl]-2-[4-(methylsulfonamido)phenoxy]ethan-1-amine oxide)
CAS:Sulfonamides, nesoiFormula:C19H27N3O6S2Color and Shape:Off-White PowderMolecular weight:457.13413Paroxetine Hydrochloride
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H20FNO3·HClH2OColor and Shape:White Off-White Crystalline PowderMolecular weight:329.14272Ambrisentan Related Compound D (2-[(2,2-Diphenylvinyl)oxy]-4,6-dimethylpyrimidine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C20H18N2OColor and Shape:Off-White Fine PowderMolecular weight:302.14191Methylisoindolinedione (2-methylisoindoline-1,3-dione)
CAS:Imides and their derivatives (excluding sacharin), and salts thereofFormula:C9H7NO2Color and Shape:White Off-White SolidMolecular weight:161.04768Rivaroxaban Related Compound D (1,3-Bis({(S)-2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)urea)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C29H32N6O9Color and Shape:Off-White White SolidMolecular weight:608.22308Ondansetron Related Compound A (3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride)
CAS:Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C16H20N2O·HClColor and Shape:White SolidMolecular weight:256.15756Levetiracetam Related Compound A ((S)-N-(1-amino-1-oxobutan-2-yl)-4-chlorobutanamide)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormula:C8H15ClN2O2Color and Shape:White Off-White CrystalsMolecular weight:206.08221O-Desmethylmetoprolol (1-(4-(2-hydroxyethyl)phenoxy)-3-(isopropylamino)propan-2-ol)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFormula:C14H23NO3Color and Shape:White Off-White SolidMolecular weight:253.16779Fluphenazine Hydrochloride
CAS:Antidepressants, tranquilizers and other pschotherapeutic agentsFormula:C22H26F3N3OS·2ClHColor and Shape:White Off-White Crystalline PowderMolecular weight:509.12822Carvedilol Related Compound C (1-(9H-Carbazol-4-yloxy)-3-(benzyl(2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol)
CAS:Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFormula:C31H32N2O4Color and Shape:Off-White PowderMolecular weight:496.23621Rotigotine Racemate ((RS)-6-{Propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H25NOSColor and Shape:Off-White CrystalsMolecular weight:315.16569Paroxetine Related Compound B ((3S,4R)-3-[(Benzodioxol-5-yloxy)methyl]-4-phenylpiperidine hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H21NO3·HClColor and Shape:White PowderMolecular weight:347.84Bupropion Hydrochloride Related Compound B (2-(tert-butylamino)-3'-bromopropiophenone hydrochloride)
CAS:Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormula:C13H18BrNO·HClColor and Shape:Off-White PowderMolecular weight:319.03385Fluticasone Propionate Related Compound D (6α,9-Difluoro-11β-hydroxy-16α-methyl-17-[(methylsulfanyl)carbonyl]-3-oxoandrosta-1,4-dien-17α-yl propanoate)
CAS:Halogenated derivatives of adrenal cortical hormonesFormula:C25H32F2O5SColor and Shape:White Off-White PowderMolecular weight:482.19385N-Isopropyl Carvedilol (1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl](1-methylethyl)amino]-2-propanol)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C27H32N2O4Color and Shape:Off-White SolidMolecular weight:448.23621Copovidone
CAS:Vinyl copolymers in primary forms, nesoiFormula:(C6H9NO)n(C4H6O2)mColor and Shape:White Yellow PowderMolecular weight:197.23 g/molDichlorothiophene Carboxylic Acid (3,5-dichlorothiophene-2-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C5H2Cl2O2SColor and Shape:White Off-White SolidMolecular weight:195.91526Fluconazole Diol (2-(2,4-Difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propane-1,2-diol)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C11H11F2N3O2Color and Shape:White SolidMolecular weight:255.08193Rotigotine Hydrochloride ((6S )-6-[Propyl(2-(2-thienyl)ethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H25NOSHClColor and Shape:White Off-White PowderMolecular weight:315.16569Labetalol Cyclohexyl Analog (5-{2-[(4-Cyclohexylbutan-2-yl)amino]-1-hydroxyethyl}-2-hydroxybenzamide hydrochloride)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C19H30N2O3·HClColor and Shape:White PowderMolecular weight:370.20232Fesoterodine Fumarate
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormula:C26H37NO3·C4H4O4Color and Shape:White Off-White PowderMolecular weight:527.2883Ambrisentan Related Compound B (2-Hydroxy-3-methoxy-3,3-diphenylpropanoic acid)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormula:C16H16O4Color and Shape:Off-White PowderMolecular weight:272.10486N6-(1-Iminoethyl)-D-lysine ((2R)-2-[(2S)-2-Aminobutanamido]butanamide)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormula:C8H17N3O2Color and Shape:White Off-White SolidMolecular weight:187.13208Erlotinib Related Compound A (4-(3-{[6,7-Bis(2-methoxyethoxy) quinazolin-4-yl]amino}phenyl)-2-methyl-3-butyn-2-ol hydrochloride)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormula:C25H29N3O5·HClColor and Shape:Off-White PowderMolecular weight:451.21072Paroxetine Related Compound C ((3R,4S)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride) OR ((+)-trans-Paroxetine hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H20FNO3·HClColor and Shape:White PowderMolecular weight:365.1194N-Nitroso Metoprolol Solution (1 mL ) (N-(2-hydroxy-3-(4-(2-methoxyethyl)phenoxy)propyl)-N-isopropylnitrous amide)
CAS:Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiFormula:C15H24N2O4Color and Shape:Colorless LiquidMolecular weight:296.17361Clozapine Benzoyl Methylpiperazine Analog (1-[2-[(2-Amino-4-chlorophenyl)amino]benzoyl]-4-methylpiperazine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C18H21ClN4OColor and Shape:Beige PowderMolecular weight:344.14039Salmeterol Resolution Check
Aromatic amino-alcohol-phenols, aromatic amino-acid-pheColor and Shape:PowderNadolol Related Compound C
Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormula:C23H28O7Color and Shape:Off-White SolidMolecular weight:416.18354-Phenylbutyl(benzyl)amine hydrochloride (N-benzyl-4-phenylbutan-1-amine, hydrochloride)
CAS:Aromatic monoamines and their derivatives, salts thereof, nesoiFormula:C17H21N·HClColor and Shape:White Off-White SolidMolecular weight:239.16742-Pyridineethanol (2-(Pyridin-2-yl)ethanol)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C7H9NOColor and Shape:Brown LiquidMolecular weight:123.06841Metoprolol Fumarate
CAS:Aromatic drugs of amino-alcohols, other than those contFormula:C34H54N2O10Color and Shape:White Off-White Crystalline PowderMolecular weight:650.8Maltol
CAS:Heterocyclic compounds with oxygen hetero-atom(s) onlyFormula:C6H6O3Color and Shape:White PowderMolecular weight:126.03169Dabigatran Etexilate Related Compound B (Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate 4-toluenesulfonate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C27H29N7O3·C7H8O3SColor and Shape:White Yellow PowderMolecular weight:671.2526Sodium Starch Glycolate Type B
CAS:Dextrins, nesoiFormula:C2H4O3·xNa·xUnspecifiedColor and Shape:Off-White White PowderMolecular weight:515.6862Argatroban Related Compound C ((2R,4R)-1-[N^8-amino- N^2-(3-methyl-1,2,3,4-tetrahydroquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid)
Sulfonamides, excluding drugsFormula:C23H37N7O5SColor and Shape:Off-White PowderMolecular weight:523.25769Desmethoxyomeprazole
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C16H17N3O2SColor and Shape:Light Brown Grey Yellow PowderMolecular weight:315.10415Bicalutamide Related Compound B ((RS)-N-(4-Cyano-3-(trifluoromethyl)phenyl)-3-(3-fluorophenylsulfonyl)-2-hydroxy-2-methylpropanamide)
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Formula:C18H14F4N2O4SColor and Shape:White Pale Pink PowderMolecular weight:430.37Metoprolol Related Compound B ((+/-)1-Chloro-2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]-propane)
CAS:Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormula:C12H17ClO3Color and Shape:Pale Yellow Clear LiquidMolecular weight:244.08662Alcohol Determination - Alcohol
CAS:Other spirituous beverages, nesoiFormula:C2H6OColor and Shape:Colorless Translucent LiquidMolecular weight:46.04186Saxagliptin Related Compound C ((1aS,4S,6aR,7aS)-4-[(1r,3R,5R,7S)-3-Hydroxyadamantan-1-yl]hexahydro-1H-cyclopropa[4,5]pyrrolo[1,2-a]pyrazine-3,6-dione)
CAS:Lactams, nesoiFormula:C18H24N2O3Color and Shape:White PowderMolecular weight:316.17869Oxcarbazepine Related Compound C (Acridin-9(10H)-one)
CAS:Aromatic or modified aromatic heterocyclic compounds wiFormula:C13H9NOColor and Shape:Yellow Green SolidMolecular weight:195.06841Nadolol Related Compound A ((2RS,3SR)-5-(2,3-Dihydroxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol)
CAS:Ether-phenols, ether-alcohol-phenols and their halogenated, sulfonated, nitrated or nitrosated derivativesFormula:C13H18O5Color and Shape:White SolidMolecular weight:254.11542S-Levetiracetam Hydroxybutyramide Analog ((S)-N-(1-amino-1-oxobutan-2-yl)-4-hydroxybutanamide)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormula:C8H16N2O3Color and Shape:White Off-White SolidMolecular weight:188.11609Ambrisentan Related Compound E (4,6-Dimethylpyrimidin-2-ol)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C6H8N2OColor and Shape:White Off-White Pale Yellow Crystalline PowderMolecular weight:124.06366Imidazole (1H-Imidazole)
CAS:Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFormula:C3H4N2Color and Shape:White Light Yellow Crystalline PowderMolecular weight:68.03745Ambrisentan
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormula:C22H22N2O4Color and Shape:White Light Yellow Crystalline PowderMolecular weight:378.15796Iodoquinol
CAS:Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFormula:C9H5I2NOColor and Shape:Light Brown Yellow PowderMolecular weight:396.84606Rivaroxaban Phthalamide (N1,N2-bis(((S)-2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)phthalamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C36H36N6O10Color and Shape:Off-White SolidMolecular weight:712.24929Brivaracetam Related Compound B ((R)-2-[(S)-2-Oxo-4-propylpyrrolidin-1-yl]butanamide)
CAS:Lactams, nesoiFormula:C11H20N2O2Color and Shape:White Off-White SolidMolecular weight:212.15248Atazanavir System Suitability Mixture (A mixture of atazanavir sulfate, atazanavir R, S, S, S,-diastereomer and atazanavir S,R,S,S diastereomer)
Compounds containing an unfused pyridine ring in the structure, nesoiColor and Shape:White Light Yellow Crystalline PowderDarunavir System Suitability Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiColor and Shape:PowderPrasugrel Hydrochloride (5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C20H20FNO3S·HClColor and Shape:White Off-White PowderMolecular weight:409.09147Methoxy Carbamazepine (10-Methoxy-5H-dibenz[b,f]azepine-5-carboxamide)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C16H14N2O2Color and Shape:White Off-White SolidMolecular weight:266.10553



